2023-08-10 04:35:56 ET
- Clinical-stage biopharmaceutical company Aptorum Group ( NASDAQ: APM ) received Nasdaq Stock Market approval for listing of Class A ordinary shares from Nasdaq Global Market to the Nasdaq Capital Market.
- On this basis, the previous two listing deficiencies regarding minimum stockholder’s equity and minimum market value of publicly held shares will be closed.
- The trading of its Class A ordinary shares will continue on Nasdaq and will not be affected.
For further details see:
Aptorum Group receives approval to transfer listing to Nasdaq Capital Markets